Drug Search Results
More Filters [+]

Ranirestat

Alternative Names: ranirestat
Latest Update: 2024-03-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: AKR Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Dainippon Sumitomo Pharma America
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Ranirestat

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Polyneuropathies

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

JapicCTI-142715

P1

Completed

Unknown

2016-06-01

JapicCTI-142753

P1

Completed

Unknown

2015-11-01

2008-002843-18

P3

Completed

Unknown

2013-01-10

AS3201-G000-291

P3

Completed

Polyneuropathies

2013-01-01

60%

Recent News Events